532 related articles for article (PubMed ID: 28748503)
1. Role of
Albano D; Bosio G; Giubbini R; Bertagna F
Jpn J Radiol; 2017 Oct; 35(10):574-583. PubMed ID: 28748503
[TBL] [Abstract][Full Text] [Related]
2.
Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693
[TBL] [Abstract][Full Text] [Related]
3. Application of
Liao F; Luo Z; Huang Z; Xu R; Qi W; Shao M; Lei P; Fan B
Contrast Media Mol Imaging; 2022; 2022():8385332. PubMed ID: 36051931
[TBL] [Abstract][Full Text] [Related]
4. FDG PET-CT in pediatric Langerhans cell histiocytosis.
Jessop S; Crudgington D; London K; Kellie S; Howman-Giles R
Pediatr Blood Cancer; 2020 Jan; 67(1):e28034. PubMed ID: 31599488
[TBL] [Abstract][Full Text] [Related]
5. Preliminary study on the evaluation of Langerhans cell histiocytosis using F-18-fluoro-deoxy-glucose PET/CT.
Zhou W; Wu H; Han Y; Wang S; Dong Y; Wang Q
Chin Med J (Engl); 2014; 127(13):2458-62. PubMed ID: 24985583
[TBL] [Abstract][Full Text] [Related]
6.
Garcia JR; Riera E; Bassa P; Mourelo S; Soler M
Rev Esp Med Nucl Imagen Mol; 2017; 36(5):325-328. PubMed ID: 28262495
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis.
Lee HJ; Ahn BC; Lee SW; Lee J
Ann Nucl Med; 2012 Nov; 26(9):730-7. PubMed ID: 22797842
[TBL] [Abstract][Full Text] [Related]
8. Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis.
Ferrell J; Sharp S; Kumar A; Jordan M; Picarsic J; Nelson A
Pediatr Blood Cancer; 2021 Apr; 68(4):e28891. PubMed ID: 33442960
[TBL] [Abstract][Full Text] [Related]
9. Fluorrine-18-fluorodeoxyglucose positron emission tomography/computed tomography of adult liver Langerhans cell histiocytosis.
Ji H; Wu J; Yang G; Sun C; Zhu H; Zhang L
Hell J Nucl Med; 2017; 20(1):97-99. PubMed ID: 28315918
[TBL] [Abstract][Full Text] [Related]
10. The added value of skeletal surveys in the initial evaluation of children diagnosed with Langerhans cell histiocytosis in the era of staging
Rameh V; Voss S; Bedoya MA; Beaulieu D; Zhang D; Degar BA; Tsai A
Pediatr Blood Cancer; 2023 Jan; 70(1):e30057. PubMed ID: 36266951
[TBL] [Abstract][Full Text] [Related]
11. Comparison of whole-body DW-MRI with 2-[
Baratto L; Nyalakonda R; Theruvath AJ; Sarrami AH; Hawk KE; Rashidi A; Shen S; States L; Aboian M; Jeng M; Daldrup-Link HE
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1689-1698. PubMed ID: 36717409
[TBL] [Abstract][Full Text] [Related]
12. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Liu Y
Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
[TBL] [Abstract][Full Text] [Related]
13. The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
An R; Ma X; Wang Y
Ann Nucl Med; 2024 Mar; 38(3):238-245. PubMed ID: 38217750
[TBL] [Abstract][Full Text] [Related]
14. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis.
Phillips M; Allen C; Gerson P; McClain K
Pediatr Blood Cancer; 2009 Jan; 52(1):97-101. PubMed ID: 18951435
[TBL] [Abstract][Full Text] [Related]
15. PET-CT in pediatric Langerhans cell histiocytosis.
Kaste SC; Rodriguez-Galindo C; McCarville ME; Shulkin BL
Pediatr Radiol; 2007 Jul; 37(7):615-22. PubMed ID: 17564738
[TBL] [Abstract][Full Text] [Related]
16. Solitary Hard Palate Langerhans Cell Histiocytosis Demonstrated on PET/CT Scan in an Adult.
Chen H; Fan Q; Su M
Clin Nucl Med; 2020 Oct; 45(10):811-812. PubMed ID: 32804762
[TBL] [Abstract][Full Text] [Related]
17. Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findings.
Binkovitz LA; Olshefski RS; Adler BH
Pediatr Radiol; 2003 Sep; 33(9):598-602. PubMed ID: 12879314
[TBL] [Abstract][Full Text] [Related]
18. The impact of
Elmanzalawy A; Vali R; Chavhan GB; Gupta AA; Omarkhail Y; Amirabadi A; Shammas A
Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
[TBL] [Abstract][Full Text] [Related]
19. 18F-Fluorodeoxyglucose PET/CT in Langerhans cell histiocytosis: spectrum of manifestations.
Agarwal KK; Seth R; Behra A; Jana M; Kumar R
Jpn J Radiol; 2016 Apr; 34(4):267-76. PubMed ID: 26759026
[TBL] [Abstract][Full Text] [Related]
20. Selective CT for PET/CT: dose reduction in Langerhans cell histiocytosis.
Gelfand MJ; Sharp SE; Palumbo JS
Pediatr Radiol; 2015 Jan; 45(1):81-5. PubMed ID: 25149158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
